Inotuzumab Ozogamicin: Efficacy, Safety, Real-World Use📉

Created using ChatSlide

In this presentation, I will delve into the intricacies of Inotuzumab Ozogamicin (InO), a pivotal targeted therapy for Acute Lymphoblastic Leukaemia (ALL). We will explore the shift towards targeted treatments, detailing the mechanism of InO, including its CD22 targeting and apoptosis induction via calicheamicin. We'll also assess its application across various treatment strategies, such as in relapsed/refractory cases and frontline therapy, while examining clinical efficacy insights from the...